Finding new ways in the approach to colorectal cancer is therefore fundamental. And there is no shortage of good news. Italy is the first country in Europe to guarantee, through the National Health ...

The bump had been present for about 3 months. The patient’s mother said there had been no bleeding, tenderness, color change, ...

hDepartment of Neurology, Center for Motor Neuron Biology and Disease and Eleanor and Lou Gehrig ALS Center, Columbia University, New York, NY, USA ...

Appropriate use of immune checkpoint inhibitors and immunotherapy differs in adults with unresectable, metastatic cutaneous ...

Explore the latest colorectal cancer treatment advances, from precision oncology and immunotherapy to ADCs, bispecifics, and ...

France's Servier has emerged as the suitor, with an all-cash offer to buy Day One and its fast-growing brain cancer therapy Ojemda (tovorafenib) for $21.50 per share, valuing the California company at ...

As nonprofit-governed Servier continues to make gains with its IDH-mutant glioma med Voranigo, the drugmaker is wading deeper into the rare oncology arena with a new M&A play.  | Servier on Friday ...

Clinical utility may be greatest with careful patient selection, given frailty-associated toxicity and potential endpoint inflation in indolent tumors, warranting larger validation cohorts and ...

Artificial intelligence tools are increasingly being developed to predict cancer biology directly from microscope images, promising faster diagnoses and cheaper testing. But new research from the ...

India, March 2 -- University of Warwick research warns that popular deep learning systems trained for cancer pathology may be relying on hidden shortcuts rather than genuine biological signals.